Related Experiment Videos
[Novel targets for cancer chemotherapy]
1Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth Science, Hokkaido University, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 1, 1996
Summary
This 1991 symposium summary highlights novel cancer chemotherapy targets, including signal transduction inhibitors and apoptosis inducers. These insights aid in developing new anticancer agents and understanding drug action mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Context:
- Proceedings from the 27th Annual Meeting of the American Society of Clinical Oncology (1991).
- Focus on novel targets for cancer therapy identified or assessed post-symposium.
Purpose:
- To summarize novel targets for cancer chemotherapy.
- To provide a foundation for developing new anticancer agents.
- To detail the significance of key targets and therapeutic agents.
Summary:
- Explores eight categories of novel cancer chemotherapy targets:
- 1. Signal transduction pathway inhibitors
- 2. Apoptosis and/or differentiation inducers
- 3. DNA-acting agents (direct and indirect)
- 4. Telomerase inhibitors
- 5. Cytoplasmic microorganism agents
- 6. Cytoplasmic metabolism inhibitors
- 7. Multidrug resistance modulators
- 8. Unknown or complex drug targets
- Includes optional lists of agents acting on these targets.
Impact:
- Provides a historical overview of emerging cancer therapeutic targets from 1991.
- Informs the ongoing development of innovative anticancer drugs.
- Facilitates understanding of diverse mechanisms in cancer chemotherapy.